Mesa Labs Reports Q2 2027 Revenue Growth and Improved EBITDA Margins

Mesa Labs (MLAB) reported second-quarter fiscal 2027 results characterized by steady revenue growth and significant margin expansion. Total revenue reached $62.3 million, a 2.6% year-over-year increase driven largely by the quality control segments. Adjusted EBITDA rose 21.1% to $17.3 million, benefiting from higher gross margins and disciplined operating expense management. The company saw strong performance in its SDC segment, which grew organically by 14.6% as production issues were resolved. While some segments like BPD and CG faced organic declines due to export-control delays and shipment timing, overall profitability improved with net income rising to $0.75 per diluted share. Management provided full-year guidance of $250 million to $255 million in revenue and reaffirmed a focus on debt reduction and cost savings.

7 articles from 3 sources · updated

Coverage